Histamine-2 Receptor Antagonist [EPC]

290710 reported adverse events

Drugs of this class: FAMOTIDINE CIMETIDINE FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE NIZATIDINE FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE IBUPROFEN AND FAMOTIDINE RANITIDINE FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE CHEWABLE TABLET LORATADINE

These side effects are most commonly reported by patients taking drugs of the Histamine-2 Receptor Antagonist [EPC] class:

# Side effect Count
0 BREAST CANCER 24527
1 PROSTATE CANCER 21798
2 COLORECTAL CANCER 17352
3 RENAL CANCER 16112
4 BLADDER CANCER 13468
5 INCORRECT DOSE ADMINISTERED 10510
6 NAUSEA 10227
7 CHRONIC KIDNEY DISEASE 10040
8 DRUG INEFFECTIVE 9695
9 FATIGUE 9422
See all common reactions for Histamine-2 Receptor Antagonist [EPC]

Drugs of the Histamine-2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COLORECTAL CANCER 17352 0.4081
1 RENAL CANCER 16112 0.3872
2 SMALL INTESTINE CARCINOMA 711 0.3778
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 335 0.3681
4 OESOPHAGEAL CARCINOMA 8257 0.3641
5 HEPATIC CANCER 6554 0.3433
6 PROSTATE CANCER 21798 0.3418
7 APPENDIX CANCER 249 0.3397
8 GASTRIC CANCER 6398 0.3217
9 HAEMATOLOGICAL MALIGNANCY 705 0.3179
See all enriched reactions for Histamine-2 Receptor Antagonist [EPC]